compound introduction
LD50 小鼠口服 26 g/kg
CAS number:3605-01-4 molecular formula:C16H18N4O2
LD50 小鼠口服 26 g/kg
| Chinese alias | - | ||
| English alias | Oprea1_061309 | BRD-K47936004-003-03-1 | EU 4200 | PIRIBEDIL [MI] | AB00514645-19 | BRN 0963637 | CAS_3605-01-4 | ES-0016 | NCGC00015857-06 | Prestwick3_000980 | 1-(2-Pyrimidyl)-4-(3,4-methylenedioxybenzyl)piperazine | Biomol-NT_000044 | BPBio1_001269 | E | ||
| CAS number | 3605-01-4 | molecular formula | C16H18N4O2 |
| molecular weight | 298.34 | Exact mass | - |
| PSA | 50.7 | logp | 1.8 |
| CAS | 3605-01-4 |
| UNII | DO22K1PRDJ |
| HMDB ID | HMDB0256595 |
| KEGG ID | D07305 |
| ChEBI ID | 92833 |
| Wikidata | Q413976 |
| ChEMBL ID | CHEMBL1256997 |
| Wikipedia | Piribedil |
| DrugBank ID | DB12478 |
| DrugCentral | 2202 |
| PubChem CID | 4850 |
| Related CAS | 3-[2-[4-[(4-氟苯基)-氧甲基]-1-哌啶基]乙基]-2-甲基-4-吡啶并[1,2-a]嘧啶酮是一种芳香酮。 |
| Nikkaji Number | C66431 |
| NCI 词表代码 | 160.25 Ų [M+H-H2O]+ [CCS类型:TW;方法:用多聚丙氨酸和药物标准校准] |
| Pharos Ligand ID | LNVMV1J7B9FK |
| DSSTox Substance ID | DTXSID9045188 |
| Metabolomics Workbench ID | 153462 |
| European Community (EC) Number | 222-764-6 |
| PubChem Reference Collection SID | 500817937 |
| International Nonproprietary Names (INN) | PIRIBEDIL |
| XLogP3 | XLogP3-AA: 1.8 |
| 复杂性 | 356 |
| Exact Mass | 298.14297583 |
| 形式电荷 | 0 |
| 重原子计数 | 22 |
| Molecular Weight | 298.34 |
| Monoisotopic Mass | 298.14297583 |
| 可旋转键计数 | 3 |
| 氢键供体计数 | 0 |
| 氢键受体计数 | 6 |
| 共价键单元计数 | 1 |
| 同位素原子计数 | 0 |
| 拓扑极性表面积 | 50.7 Ų |
| Collision Cross Section | 化学品评估:IMAP评估 - 6H-吡啶并[2,3-b][1,4]苯二氮卓-6-酮,5,11-二氢-11-[(4-甲基-1-哌嗪基)乙酰基]-:人类健康I级评估 |
| 定义键立体中心计数 | 0 |
| 定义原子立体中心计数 | 0 |
| 未定义键立体中心计数 | 0 |
| 未定义原子手性中心计数 | 0 |
No upstream information yet
No downstream information yet